Billionaire Profile
A
Global Rank
#580

Image: Lise-Marlène PUVILLAND auteure de la thèse licence d'utilisation CC BY-NC-ND 2.0 | CC BY-SA 4.0 | via Wikimedia Commons

Alain Merieux & family

CEO, Pharmaceuticals
FRANCE
Real-Time Net Worth
$6.854B
Estimated based on Pharmaceuticals stock value as of April 20, 2026
-0.95% (24h)
Age
88
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
FRANCE

Biography

Alain Mérieux, born in 1938, is a French billionaire businessman, the chairman of Institut Mérieux, and a key figure in the healthcare industry. His wealth stems from pharmaceuticals, particularly through his role in bioMérieux, a global leader in in vitro diagnostics. Mérieux's career is rooted in the legacy of his grandfather, Marcel Mérieux, a former laboratory aide to Louis Pasteur, who founded Institut Mérieux in 1897. Alain Mérieux founded bioMérieux in 1963, which specializes in diagnostic tests for infectious diseases. His contributions have earned him the title of Grand Officer in the French Legion of Honour. As of 2024, the Merieux family's net worth is estimated to be $7.4 Billion.

Fact Checked
Verified by Editorial Team
Live Data
Updated 4/20/2026

Wealth Over Time

In-Depth Profile

Early Life

Alain Mérieux was born on July 10, 1938, in Lyon, France. He is the son of Charles Mérieux and the grandson of Marcel Mérieux, who established Institut Mérieux in 1897. Growing up in a family deeply involved in medical research and diagnostics, Alain was immersed in the world of science from a young age.

Rise to Success

Alain Mérieux's career took shape when he founded bioMérieux in 1963. The company, initially known as BD Mérieux, later became a major player in in vitro diagnostics. Under his leadership, bioMérieux expanded through product development, acquisitions, and partnerships, becoming a world leader in the field. Mérieux's strategic vision led the company to develop diagnostic solutions that improve patient health and ensure consumer safety.

Key Business Strategies

Key strategies employed by Mérieux and bioMérieux include a focus on innovative diagnostics for infectious diseases, cancer screening, and cardiovascular emergencies. The company expanded its services through acquisitions of companies such as Api Systems and Vitek Systems. BioMérieux is known for its high-performance solutions in microbiology, immunoassays, and molecular biology. The company's success has been supported by its strong presence in 44 countries, serving over 160 countries through an extensive distribution network.

Philanthropy

Alain Mérieux's commitment to public health extends to philanthropy. He founded the Fondation Marcel Mérieux and the humanitarian organization Bioforce, reflecting a broader family legacy of supporting humanitarian causes. Details of the exact amounts dedicated to specific philanthropic causes are not readily available through search results.

Career Milestones

1963

Founded bioMérieux

Established bioMérieux to commercialize in vitro diagnostic solutions.

1974

Controlled BD Mérieux

Became the majority shareholder of BD Mérieux, which later became bioMérieux.

1986-1998

First Vice-President of the Rhone-Alpes Region

Oversaw foreign relations, economic development, research, and secondary education.

Philanthropy & Social Impact

Humanitarian

Fondation Marcel Mérieux

Undisclosed

Founded by Charles Mérieux, Alain's father.

Humanitarian

Bioforce

Undisclosed

A humanitarian organization founded by Charles Mérieux.